<img alt="" height="1" width="1" />Salix Pharma seeks US FDA nod for Xifaxan for treatment of Nonâ€"C IBSpharmabiz.com... (rifaximin) 550 mg tablets for the proposed indication of treatment of nonâ€"constipation irritable bowel syndrome (Nonâ€"C IBS) and IBSâ€"related bloating. ...<nobr></nobr> |